We’re increasing our Eli Lilly price target after another beat-and-raise quarter
Eli Lilly on Wednesday reported better-than-expected quarterly results and raised its full-year guidance as the company’s portfolio of…
Trump deals with Lilly, Novo Nordisk could broaden obesity drug access
US President Donald Trump makes an announcement in the Oval Office of the White House in Washington, DC…